Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Oral delivery of drugs by means of solid lipid nanoparticles
Publication

Publications

Oral delivery of drugs by means of solid lipid nanoparticles

Title
Oral delivery of drugs by means of solid lipid nanoparticles
Type
Article in International Scientific Journal
Year
2007
Authors
Silva, AC
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Santos, D
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Ferreira, DC
(Author)
FFUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page Without ORCID
Souto, EB
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. View Authenticus page Without ORCID
Journal
Vol. 19
Pages: 1-5
ISSN: 1120-4826
Scientific classification
FOS: Natural sciences > Biological sciences
Other information
Authenticus ID: P-004-BKS
Abstract (EN): Aim. Oral drug delivery can be improved through nanoencapsulation of drugs into lipid carriers. This approach takes advantages of the fact that lipids have absorption promoting properties both for lipophilic and hydrophilic drugs. Thus, if problematic drugs, e.g. poorly soluble molecules such as ibuprofen, are incorporated into lipid carriers, bioavailability of such drug molecules might be improved. In the present paper lipid based carrier systems (i.e. solid lipid nanoparticles, SLN) composed of well tolerated lipids have been produced and physicochemically characterized. Methods. The suitability of SLN to deliver ibuprofen for oral route has been assessed by means of particle size analysis. Cetyl palmitate-based SLN stabilized with a nonionic surfactant have been produced by high pressure homogenization. Results. The mean particle size of drug-free and drug-loaded SLN was 230 and 312 nm, respectively. Nonetheless, microparticles have been measured by laser diffractometry in the ibuprofen-loaded SLN formulations. Aqueous drug-free SLN dispersions have been transformed into powders by lyophilization. Scanning electron microscopy revealed spherical-like shape SLN which was maintained after freeze-drying, however with some particle aggregation. Recrystallinity index of SLN was approx. Sixty percent before and after lyophilizing the samples, and the obtained powders showed good flow properties applying the tap density test with a Carr's index of 13. Conclusion This paper reviews several analytical methodologies to characterize the dispersions in order to pre-dict their long-term stability and suitability for oral delivery of model drugs.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 5
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same authors

Risperidone Release from Solid Lipid Nanoparticles (SLN): Validated HPLC Method and Modelling Kinetic Profile (2012)
Another Publication in an International Scientific Journal
Silva, AC; Lopes, CM; Fonseca, J; Soares, ME; Santos, D; Souto, EB; Ferreira, D
Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): High pressure homogenization versus ultrasound (2011)
Article in International Scientific Journal
Silva, AC; Gonzalez Mira, E; Garcia, ML; Egea, MA; Fonseca, J; Silva, R; Santos, D; Souto, EB; Ferreira, D
Minoxidil-loaded nanostructured lipid carriers (NLC): characterization and rheological behaviour of topical formulations (2009)
Article in International Scientific Journal
Silva, AC; Santos, D; Ferreira, DC; Souto, EB
Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-08-06 at 03:04:42 | Privacy Policy | Personal Data Protection Policy | Whistleblowing